A new report from the U.S. Senate Committee on Health, Education, Labor and Pensions, led by Chairman Bill Cassidy, is calling for reforms to the 340B drug pricing program following an investigation into how covered entities utilize program revenue. The investigation, which started in September 2023, examined whether hospitals and other participants were using 340B […]
